Evaluation of recombinant interleukin-2 immunotherapy for human hemangiosarcoma in a SCID mice model (WB-SCID).

Source:http://linkedlifedata.com/resource/pubmed/id/11532372

Download in:

View as

General Info

PMID
11532372